Psoriasis Biologics Guidelines and Care Improvement Strategies
Image For Activity Cover
Availability
On-Demand
Expires on Jan 29, 2025
Credit Offered
0.5 CME Credit

Psoriasis Biologics Guidelines and Care Improvement Strategies

Date of Original Release: January 29, 2021
Date of Expiration: January 29, 2024
Estimated Time of Completion: 0.5 hour

Target Audience
Dermatologists and others involved in the delivery of dermatologic care.

Statement of Need
The American Academy of Dermatology bases its CME activities on identified professional practice gaps, the educational needs which underlie these gaps, and emerging clinical research findings as these relate to dermatology. Learners should reflect upon clinical and scientific information presented in this CME activity and determine the need for further study.

Learning Objectives
Following participation in this webinar, the learner should be able to:

  • Discuss the key recommendations of the most recent AAD psoriasis biologic guideline
  • Describe how to design an evidence-based treatment plan for patients with moderate-severe psoriasis
  • Recognize known gaps and barriers to psoriasis patients achieving satisfaction with disease management
  • Identify performance indicators, associated tools, and resources which aid in the assessment and improvement of the quality of psoriasis care

Accreditation Statement
The American Academy of Dermatology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA PRA Credit Statement
The American Academy of Dermatology designates this Enduring material for a maximum of .50 AMA PRA Category 1 CreditTM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Instructions to Claim Credit
To Claim CME credit for this activity, the learner must complete the post-activity evaluation survey.

Planners
Vidhya Hariharan, PhD - Senior Manager, Clinical Practice Guidelines Research
American Academy of Dermatology
Rosemont, IL

Karen Sharer, MPH - Manager, Quality Improvement
American Academy of Dermatology
Rosemont, IL

Sameer Malik, MD, MBA - Associate Director, Science & Clinical Guidance
American Academy of Dermatology
Rosemont, IL

Laura Vera, LSW - Associate Director, Quality Innovation
American Academy of Dermatology
Rosemont, IL

Speakers
Craig Elmets, MD, FAAD
Professor, Department of Dermatology
University of Alabama, Birmingham

Sylvia Parra, MD, FAAD
Dermatologist, Dermatology and Skin Surgery, Inc.
Sumter, South Carolina

Reviewers
Vidhya Hariharan, PhD - Senior Manager, Clinical Practice Guidelines Research
American Academy of Dermatology | Association
Rosemont, IL

Karen Sharer, MPH - Manager, Quality Improvement
American Academy of Dermatology | Association
Rosemont, IL

Staff
Christine Presta - Associate Director, Digital Learning
American Academy of Dermatology
Rosemont, IL

Andrew Theisen - Manager, Digital Learning
American Academy of Dermatology
Rosemont, IL

Christina Cortese - Senior Instructional Designer
American Academy of Dermatology
Rosemont, IL

Melinda Keske - Senior Coordinator, Digital Learning
American Academy of Dermatology
Rosemont, IL

Disclosures
All planners, speakers, reviewers, and staff for this activity reported they have no relevant relationship(s) with commercial interest(s).

Conflict Resolution Statement
In accordance with the ACCME Standards for Commercial Support of CME, the American Academy of Dermatology has implemented mechanisms, prior to the planning implementation of this enduring material activity, to identify and mitigate conflicts of interest for all individuals in a position to control the content of this enduring material activity.

Unapproved Use Disclosure
The American Academy of Dermatology requires CME faculty/authors to disclose to learners when products or procedures are being discussed are off-label (not approved for the indications being discussed), unlabeled (not approved for any indications), experimental and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. This information is intended solely for continuing medical education and is not intended to promote off-label use of these products/procedures. If you have questions, contact the medical affairs department of the manufacturer for the most recent approval information. Faculty/authors of this activity may be discussing information about pharmaceutical agents that is outside of the U.S. Food and Drug Administration approved labeling.

Disclaimer
The American Academy of Dermatology (AAD) is not responsible for statements made by the author(s). Statement or opinions expressed in this activity reflect the views of the author(s) and do not reflect the official policy of the AAD. The information provided in this CME activity is for continuing education purposes only, is not intended to establish a standard of care, and is not meant to substitute for independent medical judgment of a health provider relative to the diagnostic, management and treatment options of a specific patient’s medical condition.

No Medical Advice
The information in this publication by the American Academy of Dermatology or any third party should not be considered medical advice and is not intended to replace consultation with a qualified dermatology professional. The American Academy of Dermatology does not answer specific medical questions or refer people to a particular dermatology professional.

Contact Information
For the American Academy of Dermatology Member Resource Center, please call (866) 503-7546.


Legal notice
Copyright © 2024 American Academy of Dermatology. All rights reserved.
Reproduction or republication strictly prohibited without prior written permission.
Powered By